EARNING RECAP

Stamps.com Inc

#STMP 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q1 adjusted $1.23 est. $1.07 $136M est. $126.06M -55.75% ($36.90 closing price) $42.35 $35.25 record low; cuts FY19 adj. EPS view to $3.35-$4.85 from $5.15-$6.15 Consensus $5.43. Sees FY19 revenue $510M-$560M, consensus $554.76M
#STMP 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted $3.73 est. $2.90 $170.20M est. $160M -57.77% ($83.65 closing price) $94.34 $82.40 STMP to discontinue partnership w/ USPS says impact will last for 2 years; ees FY19 EPS $5.15-$6.15, may not compare to consensus $10.79
Q3 adjusted $2.76 est. $2.38 $143.5M est. $132.28M -9.74% ($182.47 closing price) $192.80 $177.01 raises FY18 EPS view to $10.60-$11.60 from $10.15-$11.15 Consensus $10.79. Sees FY18 revenue $550M-$580M, consensus $565.7M
Q2 $2.75 est. $2.38 $139.6M est. $134.43M +8.44% ($280.10 closing price) $284.45 $265 raises FY18 EPS view to $10.15-$11.15 from $9.60-$10.60;
Q1 adjusted $2.54 est. $1.90 $133.6M est. $122.99M +3.92% ($237.30 closing price) $240.45 $228 raises FY18 EPS view to $9.60-$10.60 from $8.80-$9.80; backs FY18 revenue view at $530M-$560M est. $546.92M;
#STMP 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted EPS $4.68 est. $2.72 $132.5M est. $120.26M +11% ( $205.30 closing) $215.76 $203.05 Q4 EBITDA up +15% YoY; sees FY18 adjusted EPS $8.80-$9.80 est. $8.33
Q3 $2.68 Vs $1.95 $115.1M Vs $111.66M -22.60% closed at $171.25 $197.12 $171.10 Raises FY17 revenue $435M-$460M, vs $455.1M consensus
Q2 $2.08 vs $1.62 $116.10M vs $99.28M +35.89%. $205.60 closing price. $206.90 $178 Raises FY17 EPS to $7.50-$8.50. Buy reaction entire day.
Q1 $1.82 Vs $1.36 105m vs -0.41% @ $110.10 $120.78 $105.20 3.12% @ $114.00 AH. FY17 $7.00-8.00 vs $6.50. Pop and fade reaction.

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.